IMM-101

IMM-101 is a drug that is being studied to see if it is useful in chemotherapy.[1] It is made from the heat-treated bacterium Mycobacterium obuense. It may have relatively few side effects compared to other drugs.[2][3]

References

  1. ↑ Dalgleish, AG; Stebbing, J; Adamson, DJ; Arif, SS; Bidoli, P; Chang, D; Cheeseman, S; Diaz-Beveridge, R; Fernandez-Martos, C; Glynne-Jones, R; Granetto, C; Massuti, B; McAdam, K; McDermott, R; Martín, AJ; Papamichael, D; Pazo-Cid, R; Vieitez, JM; Zaniboni, A; Carroll, KJ; Wagle, S; Gaya, A; Mudan, SS (6 September 2016). "Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer". British journal of cancer. doi:10.1038/bjc.2016.271. PMID 27599039.
  2. ↑ "New drug 'wakes up' immune system to fight one of deadliest cancers".
  3. ↑ "A trial looking at a new type of immunotherapy for cancer of the pancreas that can't be removed with surgery".
This article is issued from Wikipedia - version of the 9/26/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.